Our Partners
CONTINUUS
Expertise Partner
CONTINUUS Pharmaceuticals is leveraging a novel state-of-the-art pharmaceutical
manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through a Novartis-MIT research collaboration. ICM represents the most advanced method for producing small molecule drugs and enables the
entire manufacturing process, from starting materials to the final product, to be placed in a single seamless production line. This is
a fundamentally different from batch manufacturing, and offers considerable advantages in costefficiency, lead time, production flexibility, quality assurance, and environmental impact. Learn more about CONTINUUS and ICM.
Farmhispania Group
Innovation Partner
Farmhispania Group (FHG) is a CDMO at the forefront of research, development and commercialization of complex APIs, HPAPIs and cGMP advanced intermediates.
With 2 multi-purpose cGMP and FDA inspected manufacturing plants in Spain (Barcelona and Zaragoza) – FHG is housing over 120+ reactors with a total capacity of 436 m3.
FHG differential technologies include: HPAPI manufacturing (synthesis and fermentation), large scale HPLC (including HPAPI), large scale freeze drying, Flow Chemistry and Biocatalysis.
Flow Chemistry has become a key technology in FHG’s portfolio that has given access to complex and challenging reaction conditions expanding manufacturing and process chemistry’s horizons.
FHG offers a complete array of services to support small, mid-sized Biotechs and Big Pharma companies with their NCEs programs from its pre-clinical stages to NDA filing and commercialization.
TCG Lifesciences
Event Partner
TCG GreenChem, an innovative CDMO based in Princeton, New Jersey. TCG GreenChem, Inc. was conceptualized by former pharmaceutical executives with a track record in the development of hundreds of New Chemical Entities (NCE) into the clinic and commercialization of several well-known pharmaceutical products for Boehringer Ingelheim Pharmaceuticals, Inc., Sepracor, Inc., and Merck & Co, Inc. TCG GreenChem offers “Seamless CMC Development Services Including Process Research & Development and Delivery of cGMP APIs”. Our company brings the experience to meet the pharmaceutical industry’s sustainability and "green" manufacturing goals, by utilizing innovation in flow chemistry, catalysis, and green chemistry technology expertise and know-how.
TCG GreenChem is positioned as a contract innovation company with a unique modus operandi in the space of pharmaceutical R&D that supports our customers in the Pharma and the Biotech arena. TCG GreenChem is a subsidiary of TCG Lifesciences, an R&D-based manufacturing company with a track record in the supply of complex intermediates to the pharmaceutical industry, since 2001.
Some of our services include:
1. Innovative Process Research and Development activities including novel route of syntheses or optimizing the existing synthetic route for APIs.
2. Engineering catalytic transformations for intermediates of API development.
3. Automated Reaction Design and Engineering lab for reaction development crystallizations.
4. Scale-up and manufacturing capabilities in New Jersey facilities under cGMP and non-GMP for APIs (Tox batches, Phase-I and early Phase-II).
5. FDA inspected manufacturing facility in Hyderabad, India (Clininvent, TCGLS) with 180 KL capacity to support process validations, preclinical, clinical, and commercial manufacturing needs for cGMP APIs.
6. Synthesis of Stable Labelled Intermediates/APIs, Impurities, API Metabolites, Glucuronides.
7. Continuous Flow Chemistry Technologies for API development.
8. Explosion-proof and Special Hydrogenation Suite to handle pressure reactions.
9. Analytical services: Method Development, Validation, and Stability programs to support cGMP campaigns and CMC documentation.